Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine for quality of life in covert hepatic encephalopathy due to chronic hepatitis B cirrhosis
KCT0002029Phase 4Recruiting
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levocarnitine in hepatic encephalopathy (HE), Cirrhosis, hepatitis B (HBV), sponsored by Ildong Pharmaceutical Co Ltd. Started Apr 2016; status: recruiting.
02
Drugs
levocarnitine
03
Conditions
hepatic encephalopathy (HE)Cirrhosishepatitis B (HBV)
Beyond the preview
Go deeper on KCT0002029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002029.